Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Wayne Fairbrother - Principal Fellow Senior Director, Early Discovery Biochemistry

Wayne Fairbrother

Principal Fellow Senior Director, Early Discovery Biochemistry

Postdoc Mentor
"At Genentech I am surrounded by many dedicated scientists and technicians with the common goal of discovering and developing novel therapeutics to treat important human diseases."
Years at Genentech
Awards & Honors

I joined Genentech in 1992 and, together with Nick Skelton, established a Protein Nuclear Magnetic Resonance (NMR) group that focused primarily on the application of techniques for studying the solution structures of proteins and protein-protein or protein-ligand complexes of therapeutic interest. I was originally attracted to Genentech by the highly collaborative research environment, in general, and the scientists, in particular, who are dedicated to investigating important problems in biology and human disease.

Postdoctoral Mentor

I maintain an active interest in structural biology and protein NMR through interactions with the postdocs in my lab. The Postdoc Program emphasizes basic and fundamental discovery research, which allows us to continue working at the cutting edge of science. It also provides the postdoctoral fellows with a highly collaborative research environment and access to resources that are seldom available in academia.

Featured Publication

From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors.

Nat Rev Drug Discov. 2017 Apr;16(4):273-284.

Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ.